Technology as an Enabler: Strategic Implementation in Pharma
In today's pharmaceutical landscape, artificial intelligence and advanced analytics have moved from experimental initiatives to essential strategic tools.
Interested in knowing what our senior leaders think? We’ve compiled the insights from three expert sessions delivered at Pharma USA 2025 to provide you with a powerful, easy-to-digest whitepaper designed to help you stay ahead in a rapidly evolving landscape.
Access your copy of the whitepaper here >>>
This easy-to-digest whitepaper features contributions from the following:
Session 1: Case Study: Merck's Gen AI Medical Insight Innovation Project
- Patrick Leyden, Director of Medical Affairs, Merck
- Adi Zmiri, Director of Medical Affairs, Merck
Session 2: Panel: Garbage in, garbage out: Build a clean database
- Hemanth Kanakamedala, VP, Decision Science and RWE, Recursion
- Arindam Mukherjee, Director, Data Strategy & Management, Ipsen
- Paul Murasko, Head of Digital Innovation and Marketing Operations, Azurity Pharmaceuticals
- John Androsavich, General Manager, Datapoints, Ginkgo Bioworks
- Manisha Sinha, Associate Director, Speciality Data Management, Regeneron
- Aaron Mathias, VP, Corporate Strategy, nference
Session 3: Technology is the tool, not the strategy
- Moderator: Pankit Bhalodia, Partner, Healthcare & Life Sciences, West Monroe
- Venkatadri Thiruvallur, SVP & Head of US Neurology and Immunology, EMD Serono
- Letitia Snyder, VP, Vaccines, mRNA Account Management Lead, Pfizer
- Cheryl Stouch, CIO, Endo
- Anindita Sinha, VP, Commercial Operations, Shionogi
Download now! >>>
Any questions? Want to contribute to our next deep-dive? Drop me an email here! jacob.byerley@thomsonreuters.com
Kind regards,
Reuters Events is part of Reuters News & Media Ltd, 5 Canada Square, Canary Wharf, London, E14 5AQ. Registered in England and Wales: 2505735.